Results 261 to 270 of about 999,769 (295)

Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points. [PDF]

J Thorac Dis
Jovanovic D, Mogulkoc N, Sterclova M, Kramer M, Müller V, Bartos V, Plackova M, Doubkova M, Lewandowska K, Szymanowska-Narloch A, Zurkova M, Ovesna P, Vasakova MK.   +12 more
europepmc   +1 more source

The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells

British Journal of Pharmacology, Volume 183, Issue 18, Page 5516-5540, September 2026.
Background and Purpose Colorectal cancer is one of the most prevalent cancers worldwide, and novel precision medicine approaches are rapidly improving patient outcomes. Phosphodiesterase 4B (PDE4B) is a member of an enzyme family (PDE4) that hydrolyses intracellular cAMP to control spatial and temporal signalling cues.
Alina Zorn, John Daniel Pediani, Madihah Hussain, Jiayue Ling, Elaine Brown, Igor Belka, Eduardo Torres, Cathy Swindlehurst, Kyle Chan, David Stirling, George S. Baillie, Yuan Yan Sin   +11 more
wiley   +1 more source

A SNP altering the MUC5AC mucin structure is increased in idiopathic pulmonary fibrosis together with the MUC5B SNP. [PDF]

Respir Res
Trillo-Muyo S, Ermund A, Dolan B, Akyürek LM, Magnusson JM, Hansson GC.   +5 more
europepmc   +1 more source

Understanding cancer from the perspective of cellular adaptation to stressors for survival

Quantitative Biology, Volume 14, Issue 3, September 2026.
Zhenyu Huang, Xuechen Mu, Ying Xu
wiley   +1 more source

Pleuroparenchymal fibroelastosis-like findings identify an idiopathic pulmonary fibrosis subgroup with shortened telomeres and poor prognosis. [PDF]

ERJ Open Res
Otoshi R, Kitamura H, Niwa T, Murohashi K, Oda T, Baba T, Hagiwara E, Iwasawa T, Takemura T, Okudela K, Nojima Y, Nakamura Y, Mizuguchi K, Natsume-Kitatani Y, Ogura T.   +14 more
europepmc   +1 more source

Tarlatamab in Relapsed SCLC With Idiopathic Pulmonary Fibrosis: A Case With Comparative DLL3 Expression Analysis: Case Report. [PDF]

JTO Clin Res Rep
Takamura M, Tamura K, Sugito R, Takahashi N, Honma S, Yoshida M, Wakui H, Sekiguchi H, Kizawa R, Saito S, Matsubayashi S, Kiritani A, Okuda K, Utsumi H, Ito S, Minagawa S, Numata T, Hara H, Araya J.   +18 more
europepmc   +1 more source

Transcriptomic profiling of collagen gene expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Seo EJ, Park SL, Kim MK, Choi JS, Hwang HG, Kim JH, Chang HS, Park CS, Lee JU.   +8 more
europepmc   +1 more source

Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. [PDF]

BMC Pulm Med
Xu L, Zang D, Yan R, Liang Z, Yang S, Yu N, Yu X.   +6 more
europepmc   +1 more source

Cellular Senescence: Emerging Therapeutic Target for Idiopathic Pulmonary Fibrosis Pathogenic Mechanisms and Therapeutic Strategies. [PDF]

Biomol Ther (Seoul)
Suwanprakorn N, Choi Y, Choi YS, Yoo HJ, Yang SG.   +4 more
europepmc   +1 more source

Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants

Nabunje R, Guillen-Guio B, Hernandez-Beeftink T, Joof E, Leavy OC, International IPF Genetics Consortium, Maher TM, Molyneux P, Oldham JM, Noth I, Urrutia A, Aburto M, Flores C, Jenkins RG, Wain LV, Allen RJ.   +15 more
europepmc   +1 more source